VanEck Biotech ETF
BBH
106 hedge funds and large institutions have $109M invested in VanEck Biotech ETF in 2025 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 13 increasing their positions, 39 reducing their positions, and 3 closing their positions.
333% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 3
8% more funds holding
Funds holding: 98 → 106 (+8)
4.88% less ownership
Funds ownership: 34.84% → 29.97% (-4.9%)
6% less capital invested
Capital invested by funds: $115M → $109M (-$6.74M)
67% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 39
69% less call options, than puts
Call options by funds: $232K | Put options by funds: $746K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PPWM
Paragon Private Wealth Management
Lexington,
Kentucky
|
+$1.51M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$719K |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$346K |
| 4 |
Jane Street
New York
|
+$326K |
| 5 |
Raymond James Financial
St Petersburg,
Florida
|
+$305K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TWC
TD Waterhouse Canada
Toronto,
Ontario, Canada
|
-$10.5M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$1.63M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$865K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$753K |
| 5 |
PAW
Plan A Wealth
Lincoln,
Nebraska
|
-$646K |
BBH Hedge Fund Activity: Q3 2025 in Review
106 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q3 2025, worth a combined $109M — down 5.8% from $115M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new BBH positions and 3 closed out — a net gain of 10 holders — while 13 added to existing stakes and 39 trimmed.
The largest buyer was Paragon Private Wealth Management, adding an estimated $1.51M. The largest seller was TD Waterhouse Canada, cutting an estimated $10.5M.
- 106 institutional investors held VanEck Biotech ETF (BBH) as of Q3 2025, up from 98 in Q2 2025.
- Funds reported $109M of VanEck Biotech ETF stock for Q3 2025, down 5.8% quarter-over-quarter.
- 13 funds opened new VanEck Biotech ETF positions in Q3 2025 and 3 closed out, a net change of +10 holders.
- The largest VanEck Biotech ETF buyer in Q3 2025 was Paragon Private Wealth Management, an estimated $1.51M added.
- The largest VanEck Biotech ETF seller in Q3 2025 was TD Waterhouse Canada, an estimated $10.5M sold.
Based on aggregated 13F filings for Q3 2025.